Daurismo
These highlights do not include all the information needed to use DAURISMO safely and effectively. See full prescribing information for DAURISMO. DAURISMO™ (glasdegib) tablets, for oral use Initial U.S. Approval: 2018
204a6f7e-c9a4-472b-abd2-9527bda64d17
HUMAN PRESCRIPTION DRUG LABEL
Nov 2, 2023
Pfizer Laboratories Div Pfizer Inc
DUNS: 134489525
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
glasdegib
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
glasdegib
Product Details
FDA regulatory identification and product classification information